US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Clinical Trial Market Research Reports & Industry Analysis

RSS Feeds

Clinical Trial Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Cyclin-Dependent Kinase 1 (CDK1) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... report is to establish the understanding for all the pipeline drugs that fall under Cyclin-Dependent Kinase 1 (CDK1) Inhibitors. This report provides information on the therapeutic development based on the Cyclin-Dependent Kinase 1 (CDK1) Inhibitors ...  |  read more...
USD 1,250
Vasopressin Receptor Agonists -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Vasopressin Receptor Agonists. This report provides information on the therapeutic development based on the Vasopressin Receptor Agonists dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Vasopressin V1a Receptor (V1aR) Antagonists -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... report is to establish the understanding for all the pipeline drugs that fall under Vasopressin V1a Receptor (V1aR) Antagonists. This report provides information on the therapeutic development based on the Vasopressin V1a Receptor (V1aR) Antagonists ...  |  read more...
USD 1,250
Vasopressin V2 Receptor (V2R) Antagonists -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... report is to establish the understanding for all the pipeline drugs that fall under Vasopressin V2 Receptor (V2R) Antagonists. This report provides information on the therapeutic development based on the Vasopressin V2 Receptor (V2R) Antagonists ...  |  read more...
USD 1,250
Viral Protease Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Viral Protease Inhibitors. This report provides information on the therapeutic development based on the Viral Protease Inhibitors dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Congenital Hypoplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Myelodysplastic Syndrome Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Testogel-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
Sprycel-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
Genital Herpes- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Chronic Urticaria Or Hives Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs ...  |  read more...
USD 2,000
Herpes Simplex Infections Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
HIV Protease Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under HIV Protease Inhibitors. This report provides information on the therapeutic development based on the HIV Protease Inhibitors dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
HIV-2 Protease (HIV-2 PR) Inhibitors -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... report is to establish the understanding for all the pipeline drugs that fall under HIV-2 Protease (HIV-2 PR) Inhibitors. This report provides information on the therapeutic development based on the HIV-2 Protease (HIV-2 PR) Inhibitors ...  |  read more...
USD 1,250
Dental Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and ...  |  read more...
USD 2,000
Moderate Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and ...  |  read more...
USD 2,000
Neuropathic Pain- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and ...  |  read more...
USD 2,000
Other Pain Disorders- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different ...  |  read more...
USD 2,000
Perennial Allergic Rhinitis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Cardiogenic Shock Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Chronic Asthma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Xolair-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
Duagene-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
Telavic-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
Xyzall-Drug Insights,2014
11/21/2014 | published by: DelveInsight
... US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report ...  |  read more...
USD 1,000
6  7  8  9    11    13  14  15